Skip Navigation LinksHome > March 2013 - Volume 25 - Issue 3 > Clinical significance of microRNA-93 downregulation in human...
European Journal of Gastroenterology & Hepatology:
doi: 10.1097/MEG.0b013e32835c077a
Original Articles: Colorectal Neoplasia

Clinical significance of microRNA-93 downregulation in human colon cancer

Xiao, Zhi-Ganga,b; Deng, Zhan-Shenga; Zhang, Yang-Dea; Zhang, Yanga; Huang, Zhong-Chengb

Collapse Box


Aim: MicroRNA-93 (miR-93) has been shown to suppress proliferation and colony formation of colon cancer stem cells. The aim of this study was to examine the expression pattern and prognostic value of miR-93 in patients with colon cancer.

Materials and methods: A quantitative real-time PCR analysis was carried out to detect the expression levels of miR-93 in 138 paired samples of tumoral and nontumoral colon tissues diagnosed with colon cancer. Associations of miR-93 expression with clinicopathological parameters and survival were also examined.

Results: miR-93 expression was significantly decreased in tumoral compared with nontumoral colon tissues (P<0.001). Low miR-93 expression was significantly correlated with advanced tumor stage (P=0.02), positive nodal metastasis (P=0.006), and positive distant metastases (P=0.01). In addition, Kaplan–Meier survival analysis by Cox regression showed that low miR-93 expression [hazard ratio (HR), 10.2; 95% confidence interval (CI), 1.9–42.8, P=0.003] was associated closely with poor overall survival in patients with colon cancer. Moreover, multivariate analysis showed that miR-93 decreased expression (HR, 4.3; 95% CI, 0.8–17.2, P=0.02), advanced tumor stage (HR, 3.1; 95% CI, 0.2–13.9, P=0.04), positive nodal metastasis (HR, 4.1; 95% CI, 0.7–16.8, P=0.02), and positive distant metastases (HR, 3.7; 95% CI, 0.5–14.1, P=0.03) were independent risk factors for overall survival in patients with colon cancer.

Conclusion: Our data show for the first time that the downregulation of miR-93 was significantly correlated with unfavorable clinicopathologic features and short overall survival in patients with colon cancer, suggesting that decreased expression of miR-93 be used as a novel prognostic factor for this disease.

© 2013 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.